+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beta Hydroxybutyrate Test"

2024-2028 Global Beta-Hydroxybutyrate Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Thumbnail Image

2024-2028 Global Beta-Hydroxybutyrate Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • October 2024
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Beta Hydroxybutyrate Test is a point-of-care diagnostic test used to measure the concentration of beta-hydroxybutyrate (BHB) in a patient's blood. BHB is a ketone body produced by the body during periods of fasting or carbohydrate restriction, and is used to diagnose and monitor conditions such as diabetes, ketoacidosis, and metabolic disorders. The test is typically performed using a handheld device, and results are available within minutes. The Beta Hydroxybutyrate Test market is a rapidly growing segment of the point-of-care diagnostics industry. The test is increasingly being used in clinical settings to diagnose and monitor a variety of conditions, and is becoming an important tool for healthcare providers. Some companies in the Beta Hydroxybutyrate Test market include Abbott, Roche, Siemens, and Alere. Show Less Read more